Oncocyte secures $29.1 million to advance FDA assay

Science and Technology Science and Technology

Mon, February 10, 2025

[ Mon, Feb 10th ] - WKTV

AI Wants to Fix Your Love Life. Can It Really Be Hacked?

[ Mon, Feb 10th ] - MSN

Women's rights activist blasts museum tour claiming Legos are 'heteronormative,' anti-LGBT

[ Mon, Feb 10th ] - MSN

Engineers design new autonomous system to monitor Arctic's melting ice

[ Mon, Feb 10th ] - MSN

Benefit dinner held for families affected by Mifflin County rowhome fire

[ Mon, Feb 10th ] - MSN

Superconducting nanowire LiDAR can scan your face from 325 meters away

[ Mon, Feb 10th ] - MSN

Russia's scientific exodus: Universities face budget crisis

[ Mon, Feb 10th ] - MSN

Machine learning method improves semiconductor band gap predictions

[ Mon, Feb 10th ] - MLive

Without federal funding, Michigan youth STEM program suddenly shuts down

[ Mon, Feb 10th ] - MSN

How Does The Fantastic Four's Human Torch Fly? Thanks to Science, We Have an Answer

[ Mon, Feb 10th ] - MSN

MIT's robotic insects take flight: Boosting agricultural yields

[ Mon, Feb 10th ] - MSN

Women in STEM fields in spotlight on international day

[ Mon, Feb 10th ] - MSN

"Gone too soon": SA mourns death of Senamile Masango, first black nuclear physicist

[ Mon, Feb 10th ] - MSN

UK to establish agritech hub in Oyo

[ Mon, Feb 10th ] - Sky

What is the AI Action Summit in Paris and what outcomes can we expect?

[ Mon, Feb 10th ] - Vanguard

Saleeman Adedoyin Saleeman: A leading tech innovator with a purpose

[ Mon, Feb 10th ] - MSN

Electromagnetic wave absorber enhances terahertz technology for future 6G networks

[ Mon, Feb 10th ] - MSN

Green hydrogen is a clean fuel, but South Africa' .. t ready to produce it: Energy experts explain why

[ Mon, Feb 10th ] - MSN

'AI is rewiring technology and accelerating human .. ichai urges policymakers to consider its benefits

[ Mon, Feb 10th ] - MSN

The Magnetic Pole Shift That Could Plunge Us Into Chaos

[ Mon, Feb 10th ] - MSN

Exclusive-Germany's Merck KGaA in talks to buy US biotech firm Springworks, sources say

[ Mon, Feb 10th ] - Invezz

MuskIt Launches Major 100M Token Buyback to Strengthen Utility and Drive Growth

[ Mon, Feb 10th ] - BBC

South Africa mourn di death of dia first female nuclear scientist wey die at 37

[ Mon, Feb 10th ] - MSN

Civ 7: How To Take Advantage Of Dark Ages

[ Mon, Feb 10th ] - MSN

Jitendra Singh launches Srjanam at AIIMS

[ Mon, Feb 10th ] - BBC

South Africa mourns pioneering female nuclear scientist

[ Mon, Feb 10th ] - MSN

Nuclear Power: The Overlooked Ally in the Fight Against Climate Change?

[ Mon, Feb 10th ] - MSN

Robot dogs use lasers to detect and disarm bombs in a test by the British Ministry of Defence

[ Mon, Feb 10th ] - MSN

Okta names Eric Kelleher as new President and COO

[ Mon, Feb 10th ] - MSN

Disability benefits claims are about to get quicker using AI

[ Mon, Feb 10th ] - MSN

Oncocyte secures $29.1 million to advance FDA assay

^{Published on 2025-02-10 10:02:19 - MSN}

IRVINE, Calif. - Oncocyte Corp. (NASDAQ: OCX), a diagnostics technology company, has announced a funding round led by existing investors, including strategic partner Bio-Rad Laboratories, Inc. (NYSE: NYSE:BIO),

Oncocyte Corporation has successfully raised $29.1 million through a private placement of common stock and warrants, aimed at advancing its FDA-cleared VitaGraft™ Kidney assay. This financial boost will support the company's efforts to expand its product offerings in the transplant monitoring sector. The VitaGraft Kidney assay, which measures donor-derived cell-free DNA (dd-cfDNA) to assess kidney transplant health, has already received FDA clearance and is designed to help clinicians detect rejection early, potentially improving patient outcomes. The funds will also be used for general corporate purposes, including working capital and further development of Oncocyte's diagnostic pipeline.

Read the Full MSN Article at:
[ https://www.msn.com/en-us/science/biology/oncocyte-secures-29-1-million-to-advance-fda-assay/ar-AA1yKVrB ]

Contributing Sources

MSN

N@N

Oncocyte secures $29.1 million to advance FDA assay